T1	duration 52 58	5-year
T2	intervention 115 145	prone breast radiation therapy
T3	duration 264 285	Between 2003 and 2006
T4	No-of-participants 287 290	404
T5	eligibility 291 329	patients with stage I-II breast cancer
T6	outcome 1262 1337	5-year cumulative incidence of isolated ipsilateral breast tumor recurrence
T7	outcome 1396 1446	5-year cumulative incidence of regional recurrence
T8	outcome 1487 1523	5-year overall cumulative death rate
T9	outcome 1604 1656	judged their final cosmetic result as excellent/good
